On November 23, SungenBio as China's only natto physiologically active substance production quality management demonstration base, was invited by the China Pharmaceutical Quality Management Association to participate in the 2018 China Medical Quality Annual Conference, and held " Innovation Leads to a Small Change in the World——New Development of Natto Industry (Nattokinase · Vitamin K2) "Forum, more than 100 people from domestic and foreign medical experts, scholars and business representatives participated, invited authoritative experts from Shenyang Pharmaceutical University, Dalian Medical University, etc .They introduced the revolutionary health effects of nattokinase and vitamin K2, and introduced the scientific research work of SungenBio in the quality management of nattokinase and vitamin K2.

In addition, SungenBio will formally submit an application to the China Pharmaceutical Quality Management Association. It is planned to formulate a Nattokinase raw material industry standard and establish a Nattokinase Association next year, to promote the rapid development of Nattokinase in the production quality management system and the industrialization of results.